Original Article
Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension Steven M. Smith a, Yan Gong b, Eileen Handberg c, Franz H. Messerli d, George L. Bakris e, Ali Ahmed f, Anthony A. Bavry c, Carl J. Pepine c, and Rhonda M. Cooper-DeHoff b,c
Objective: Resistant hypertension (res-HTN) is a challenging problem, but little is known of res-HTN in patients with coronary artery disease (CAD). In this posthoc INternational VErapamil SR-Trandolapril STudy (INVEST) analysis, we assessed prevalence, predictors, and impact on outcomes of res-HTN in CAD patients with hypertension. Methods: Participants (n ¼ 17 190) were divided into three groups according to achieved blood pressure (BP): controlled (BP
Predictors and outcomes of resistant hypertension among patients with coronary artery disease and hypertension Steven M. Smith a, Yan Gong b, Eileen Handberg c, Franz H. Messerli d, George L. Bakris e, Ali Ahmed f, Anthony A. Bavry c, Carl J. Pepine c, and Rhonda M. Cooper-DeHoff b,c
Objective: Resistant hypertension (res-HTN) is a challenging problem, but little is known of res-HTN in patients with coronary artery disease (CAD). In this posthoc INternational VErapamil SR-Trandolapril STudy (INVEST) analysis, we assessed prevalence, predictors, and impact on outcomes of res-HTN in CAD patients with hypertension. Methods: Participants (n ¼ 17 190) were divided into three groups according to achieved blood pressure (BP): controlled (BP
